Cloned (Comment) | Organism |
---|---|
gene PYR2, recombinant expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21 (DE3) pLysS | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
R119C | mutation identified in patient with microcephaly and hypomyelination, mutant is catalytically impaired | Homo sapiens |
R119C | a naturally occuring mutation in patients with microcephaly and hypomyelination. The mutant is catalytically impaired, depending on whether NADPH or NADH is used, the catalytic efficiency of the R119C protein variant is 40 or 366 times lower than that of the wild-type enzyme | Homo sapiens |
R251C | mutation identified in patient with microcephaly and hypomyelination, mutant is catalytically impaired and has a pronounced folding defect | Homo sapiens |
R251C | a naturally occuring mutation in patients with microcephaly and hypomyelination. The mutant is catalytically impaired, depending on whether NADPH or NADH is used, the catalytic efficiency of the R119C protein variant is 7 or 26 times lower than that of the wild-type enzyme. The R251C protein variant has a pronounced folding defect. The R251C variant displays the least overall regular alpha-helical character of the PYCR2 proteins, yet the R251C variant also displays strong overall regular beta-strand or beta-sheet character | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
L-proline | at 0-500 microM, the value of KMapp increases whereas Vlim remains fairly unchanged, which is consistent with competitive inhibition | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | steady-state kinetics of the wild-type enzyme and mutants | Homo sapiens | |
0.03 | - |
NADH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
0.034 | - |
NADH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.119 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.12 | - |
NADPH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
0.216 | - |
NADPH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.22 | - |
NADPH | wild-type, pH 7.5, 37°C | Homo sapiens | |
0.298 | - |
NADH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.3 | - |
NADH | wild-type, pH 7.5, 37°C | Homo sapiens | |
0.317 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADH | Homo sapiens | |
0.32 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
0.33 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
0.334 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADPH | Homo sapiens | |
0.537 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.54 | - |
NADPH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
0.949 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADPH | Homo sapiens | |
0.95 | - |
NADH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
0.953 | - |
NADH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.99 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
1.315 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADH | Homo sapiens | |
1.32 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
1.499 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADPH | Homo sapiens | |
1.5 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
1.509 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADH | Homo sapiens | |
1.51 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Homo sapiens | 5739 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-pyrroline-5-carboxylate + NADH + H+ | Homo sapiens | - |
L-proline + NAD+ | - |
? | |
1-pyrroline-5-carboxylate + NADPH + H+ | Homo sapiens | - |
L-proline + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q96C36 | - |
- |
Homo sapiens | Q96C36 | isoform PYRC2 | - |
Purification (Comment) | Organism |
---|---|
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21 (DE3) pLysS by nickel affinity chromatography, dialysis, and ultrafiltration | Homo sapiens |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
L-proline + NAD(P)+ = 1-pyrroline-5-carboxylate + NAD(P)H + H+ | enzyme PYCR2 kinetics suggest a sequential binding mechanism with L-P5C binding before NAD(P)H and NAD(P)+ releasing before L-Pro | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
epithelium | - |
Homo sapiens | - |
esophageal squamous cell carcinoma cell | - |
Homo sapiens | - |
skeletal muscle | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-pyrroline-5-carboxylate + NADH | - |
Homo sapiens | L-proline + NAD+ | - |
? | |
1-pyrroline-5-carboxylate + NADH + H+ | - |
Homo sapiens | L-proline + NAD+ | - |
? | |
1-pyrroline-5-carboxylate + NADPH | - |
Homo sapiens | L-proline + NADP+ | - |
? | |
1-pyrroline-5-carboxylate + NADPH + H+ | - |
Homo sapiens | L-proline + NADP+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
DELTA1-pyrroline-5-carboxylate reductase 2 | - |
Homo sapiens |
PYCR2 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
54 | 79 | PYCR2 wild-type and mutant R119C exhibit fairly sharp unfolding transitions and similar Tm values of 69°C and 67°C, respectively, whereas mutant R251C exhibits a dramatically lower Tm value of 54°C. Incubation of each PYCR2 enzyme with product ligands, L-Pro and NAD+, individually or together has no effect on the observed Tm values | Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.015 | - |
NADH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
0.015 | - |
NADH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
0.08 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
0.08 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADH | Homo sapiens | |
0.13 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
0.13 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADPH | Homo sapiens | |
1.5 | - |
NADPH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
1.5 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
1.8 | - |
NADPH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
1.8 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
3.1 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
3.1 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADPH | Homo sapiens | |
3.2 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
3.2 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADH | Homo sapiens | |
5.9 | - |
NADH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
5.9 | - |
NADH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
24 | - |
NADPH | wild-type, pH 7.5, 37°C | Homo sapiens | |
24 | - |
NADPH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
26 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
26 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADPH | Homo sapiens | |
47.9 | - |
NADH | wild-type, pH 7.5, 37°C | Homo sapiens | |
47.9 | - |
NADH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
61.3 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
61.3 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADH | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
additional information | PYCR2 does not show a strong preference for NADH or NADPH | Homo sapiens | |
NAD+ | - |
Homo sapiens | |
NADH | - |
Homo sapiens | |
NADP+ | - |
Homo sapiens | |
NADPH | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | product(s) inhibition kinetics are analyzed by global fitting of the data to different inhibition models | Homo sapiens | |
0.145 | - |
L-proline | pH 7.5, 37°C, recombinant wild-type enzyme, competitive inhibition | Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | in a mass spectrometry-based screening of metabolites in tissue sections from 256 esophageal squamous cell carcinoma (ESCC) patients, a significant upregulation of L-proline metabolism is found in the cancer region compared to the normal epithelium and muscle regions. Immunohistochemistry staining of the ESCC tissue sections identifies PYCR2 as the most enriched metabolic enzyme in the cancer region, consistent with increased L-proline found in the same tissue region | up |
General Information | Comment | Organism |
---|---|---|
malfunction | homozygous mutations in human PYCR2 lead to postnatal microcephaly and hypomyelination, including hypomyelinating leukodystrophy type 10. PYCR2 mutations are detected in patients with lethal microcephaly, loss of PYCR2 is proposed to impair mitochondria function and disrupt oxidative balance, namely NAD(P)+ levels. The R251C variant displays the least overall regular alpha-helical character of the PYCR2 proteins, yet the R251C variant also displays strong overall regular beta-strand or beta-sheet character | Homo sapiens |
metabolism | sequential binding mechanism with 1-pyrroline-5-carboxylate binding before NAD(P)H and NAD(P)+ releasing before L-Pro | Homo sapiens |
metabolism | the enzyme is involved in the proline metabolism in the mitochondrion, overview | Homo sapiens |
physiological function | pyrroline-5-carboxylate reductase (PYCR in humans) catalyzes the final step of L-proline biosynthesis by catalyzing the reduction of L-DELTA1-pyrroline-5-carboxylate (L-P5C) to L-proline using NAD(P)H as the hydride donor. In humans, three isoforms PYCR1c, and PYCR3 are known. Isozyme PYCR3 is a cytosolic enzyme whereas PYCR1 and PYCR2 are identified as mitochondrial isozymes. PYCR2 not only drives cellular supply of L-proline but it is also important for redox cycling of NAD(P)H/NAD(P)+ | Homo sapiens |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.25 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
0.25 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADH | Homo sapiens | |
0.39 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R119C, with NADPH | Homo sapiens | |
0.4 | - |
1-pyrroline-5-carboxylate | mutant R119C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
0.44 | - |
NADH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
0.441 | - |
NADH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
2.07 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADPH | Homo sapiens | |
2.1 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
2.4 | - |
1-pyrroline-5-carboxylate | mutant R251C, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
2.43 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant mutant R251C, with NADH | Homo sapiens | |
2.793 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R119C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
2.8 | - |
NADPH | mutant R119C, pH 7.5, 37°C | Homo sapiens | |
6.19 | - |
NADH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
6.2 | - |
NADH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
15 | - |
NADPH | mutant R251C, pH 7.5, 37°C | Homo sapiens | |
15.13 | - |
NADPH | pH 7.5, 37°C, recombinant mutant R251C, with 1-pyrroline-5-carboxylate | Homo sapiens | |
26 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADPH, pH 7.5, 37°C | Homo sapiens | |
27.4 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADPH | Homo sapiens | |
40.62 | - |
1-pyrroline-5-carboxylate | pH 7.5, 37°C, recombinant wild-type enzyme, with NADH | Homo sapiens | |
41 | - |
1-pyrroline-5-carboxylate | wild-type, cosubstrate NADH, pH 7.5, 37°C | Homo sapiens | |
111 | - |
NADPH | wild-type, pH 7.5, 37°C | Homo sapiens | |
111.11 | - |
NADPH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
160.74 | - |
NADH | pH 7.5, 37°C, recombinant wild-type enzyme, with 1-pyrroline-5-carboxylate | Homo sapiens | |
161 | - |
NADH | wild-type, pH 7.5, 37°C | Homo sapiens |